pteridines has been researched along with Animal Mammary Carcinoma in 1 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| " Treatment of syngeneic R3T or 4T1 tumor-bearing mice with orally given SD-208 inhibited primary tumor growth as well as the number and size of metastases." | 3.73 | Inhibition of growth and metastasis of mouse mammary carcinoma by selective inhibitor of transforming growth factor-beta type I receptor kinase in vivo. ( Barnard, N; Chakravarty, J; Dugar, S; Ge, R; Lattime, E; Medicherla, S; Murphy, A; Protter, A; Rajeev, V; Ray, P; Reiss, M; Rittling, S; Schreiner, G, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ge, R | 1 |
| Rajeev, V | 1 |
| Ray, P | 1 |
| Lattime, E | 1 |
| Rittling, S | 1 |
| Medicherla, S | 1 |
| Protter, A | 1 |
| Murphy, A | 1 |
| Chakravarty, J | 1 |
| Dugar, S | 1 |
| Schreiner, G | 1 |
| Barnard, N | 1 |
| Reiss, M | 1 |
1 other study available for pteridines and Animal Mammary Carcinoma
| Article | Year |
|---|---|
Inhibition of growth and metastasis of mouse mammary carcinoma by selective inhibitor of transforming growth factor-beta type I receptor kinase in vivo.
Topics: Animals; Antineoplastic Agents; Apoptosis; Carcinoma; Cell Proliferation; Disease Progression; Epith | 2006 |